Maxcyte (MXCT) EBIT Margin Growth (3y) (2023 - 2026)
Maxcyte (MXCT) EBIT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn | 244.00 |
| 10 | Maxcyte | 146.35 Mn | 146.35 Mn | 5.60 Mn | 384.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 384.00 |
| Mar 31, 2026 | 12,806.00 |
| Dec 31, 2025 | 32,243.00 |
| Sep 30, 2025 | -13,473.00 |
| Jun 30, 2025 | -7,628.00 |
| Mar 31, 2025 | -8,244.00 |
| Dec 31, 2024 | -14,704.00 |
| Sep 30, 2024 | -14,804.00 |
| Jun 30, 2024 | -17,895.00 |
| Mar 31, 2024 | -6,948.00 |
| Dec 31, 2023 | 1,580.00 |
| Sep 30, 2023 | -27,483.00 |
| Jun 30, 2023 | -2,228.00 |